The Recall Desk
ModerateFDA (Drugs)·D-0725-2021·Announced 2021-08-25

Combipatch Transdermal Patch Recall Due to Stability Failure

Noven Pharmaceuticals is recalling certain lots of Combipatch (estradiol/norethindrone acetate transdermal system) distributed nationwide because the patches failed stability testing and fell out of specification for shear properties.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall for a stability and manufacturing-specification failure. No illnesses, injuries, or deaths are reported in the source text. The hazard is potential reduced efficacy or delivery inconsistency due to out-of-specification shear properties, which is a quality and performance issue rather than an acute safety threat.

Plain-English summary

Noven Pharmaceuticals Inc is recalling Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day in packages of 2 systems (NDC 68968-0525-2) and 8 systems (NDC 68968-0525-8). The recall affects lots 88540 (expiration 03/2022), 89118 (expiration 05/2022), 89244 (expiration 07/2022), and a sample lot 89244 (expiration 07/2022). The product was distributed nationwide.

The patches are being recalled because they failed stability specifications and were found to be out of specification for shear properties. Shear refers to the physical integrity and adhesive properties of the transdermal patch.

Patients who have this product should consult their healthcare provider about continued treatment options. Healthcare providers and patients who have questions about this recall can contact Noven Therapeutics LLC or the FDA for more information.

The recalled product

Product
COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM) (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)
Brand
COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)
Manufacturer
Noven Pharmaceuticals Inc
Category
Drug — Transdermal Patch / Hormone Replacement
Hazard
  • stability-failure
  • manufacturing-specification
  • patch-integrity

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lots: 88540 Exp. 03/2022
  • 89118 Exp. 05/2022
  • 89244 Exp. 07/2022
  • 89244 (sample lot) Exp. 07/2022

Distribution

Distributed nationwide across the United States.

Related recalls

Same brand · COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)

Same category